Applied BiosignalsMeasurement & Analysis

Applied Biosignals GmbH participates in the NeoVitAI Networking Event in Groningen

On 10–11 November 2026, representatives of Applied Biosignals GmbH, a project partner in NeoVitAI, participated in two days of NeoVitAI activities in Groningen, the Netherlands.

On 10 November, more than 25 representatives from the ten project partners met to discuss the opportunities, challenges and added value of AI in neonatology from clinical, technological and regulatory perspectives.

On 11 November, the public networking event took place at the FC Groningen stadium (Euroborg), featuring expert keynote presentations, a panel discussion on the human dimension and responsible use of AI in neonatal care, interactive demonstrations of AI applications by project partners, and opportunities for networking and collaboration.

NeoVitAI is a cross-border project funded by the Interreg VI Germany–Netherlands programme. It brings together ten partners from both countries to promote the responsible, sustainable and practical implementation of AI in healthcare. With neonatal care, particularly the care of premature babies, as its initial focus, the project explores how AI can support healthcare professionals, improve patient care and be safely integrated into clinical practice. One of its key objectives is to develop a practical implementation handbook to support the wider adoption of AI in healthcare.

NeoVitAI Group Photo

The NeoVitAI project is carried out within the framework of the INTERREG VI programme Deutschland-Nederland and is financially supported by:

NeoVitAI funding partners

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the programme partners. Neither the European Union nor the programme partners can be held responsible for them.

‹ All news